Cell Point (India) Limited (NSE:CELLPOINT)
India · Delayed Price · Currency is INR 15.20
-0.40 (-2.56%)
Feb 19, 2026, 12:28 PM IST
Cell Point (India) Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 3,481 | 3,247 | 3,212 | 2,957 | 2,692 | 2,230 |
Other Revenue | 0 | - | -0 | - | - | - |
| 3,481 | 3,247 | 3,212 | 2,957 | 2,692 | 2,230 | |
Revenue Growth (YoY) | 9.82% | 1.08% | 8.64% | 9.85% | 20.69% | -19.65% |
Cost of Revenue | 2,908 | 2,702 | 2,698 | 2,386 | 2,214 | 1,871 |
Gross Profit | 573.83 | 544.63 | 514.21 | 570.96 | 477.47 | 359.55 |
Selling, General & Admin | 232.05 | 232.59 | 217.92 | 194.45 | 189.43 | 155.08 |
Other Operating Expenses | 271.57 | 237.9 | 209.63 | 196.22 | 180.12 | 124.33 |
Operating Expenses | 517.48 | 502.76 | 446.18 | 400.12 | 380.76 | 291.45 |
Operating Income | 56.34 | 41.87 | 68.03 | 170.83 | 96.71 | 68.1 |
Interest Expense | -52.54 | -47.9 | -52.06 | -70 | -64.28 | -26.03 |
Interest & Investment Income | 4.57 | 4.57 | 7.87 | 8.32 | 5.97 | 2.78 |
Other Non Operating Income (Expenses) | -4.21 | 6.14 | 3.37 | -10.48 | -14.13 | -32.14 |
EBT Excluding Unusual Items | 4.16 | 4.68 | 27.21 | 98.68 | 24.28 | 12.71 |
Other Unusual Items | 23.46 | 23.46 | - | - | - | - |
Pretax Income | 27.62 | 28.14 | 27.21 | 98.68 | 24.28 | 12.71 |
Income Tax Expense | 5.34 | 5.53 | 10.28 | 31.43 | 7.81 | 5.8 |
Net Income | 22.28 | 22.62 | 16.93 | 67.25 | 16.46 | 6.91 |
Net Income to Common | 22.28 | 22.62 | 16.93 | 67.25 | 16.46 | 6.91 |
Net Income Growth | 869.63% | 33.56% | -74.82% | 308.50% | 138.21% | -56.80% |
Shares Outstanding (Basic) | 19 | 19 | 18 | 14 | 14 | 14 |
Shares Outstanding (Diluted) | 19 | 19 | 18 | 14 | 14 | 14 |
Shares Change (YoY) | 0.03% | 6.51% | 28.51% | - | -0.09% | 0.08% |
EPS (Basic) | 1.19 | 1.21 | 0.97 | 4.93 | 1.21 | 0.51 |
EPS (Diluted) | 1.19 | 1.21 | 0.97 | 4.93 | 1.21 | 0.51 |
EPS Growth | 869.09% | 25.37% | -80.41% | 308.50% | 138.42% | -56.83% |
Free Cash Flow | -183.73 | -56.87 | -370.9 | 36.64 | -8.11 | 11.94 |
Free Cash Flow Per Share | -9.82 | -3.04 | -21.14 | 2.68 | -0.59 | 0.87 |
Dividend Per Share | - | - | 0.250 | - | - | - |
Gross Margin | 16.48% | 16.77% | 16.01% | 19.31% | 17.74% | 16.12% |
Operating Margin | 1.62% | 1.29% | 2.12% | 5.78% | 3.59% | 3.05% |
Profit Margin | 0.64% | 0.70% | 0.53% | 2.27% | 0.61% | 0.31% |
Free Cash Flow Margin | -5.28% | -1.75% | -11.55% | 1.24% | -0.30% | 0.53% |
EBITDA | 46.75 | 50.68 | 86.65 | 180.29 | 107.92 | 80.15 |
EBITDA Margin | 1.34% | 1.56% | 2.70% | 6.10% | 4.01% | 3.59% |
D&A For EBITDA | -9.59 | 8.81 | 18.62 | 9.45 | 11.21 | 12.04 |
EBIT | 56.34 | 41.87 | 68.03 | 170.83 | 96.71 | 68.1 |
EBIT Margin | 1.62% | 1.29% | 2.12% | 5.78% | 3.59% | 3.05% |
Effective Tax Rate | 19.34% | 19.64% | 37.77% | 31.85% | 32.18% | 45.64% |
Revenue as Reported | 3,487 | 3,263 | 3,229 | 2,970 | 2,700 | 2,236 |
Advertising Expenses | - | 27.57 | 27.54 | 20.91 | 23.34 | 11.92 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.